Middle East & Africa Crispr And Cas Genes Market Size & Outlook
Middle East & Africa crispr and cas genes market, 2018-2030 (US$M)
Related Markets
MEA crispr and cas genes market highlights
- The MEA crispr and cas genes market generated a revenue of USD 107.8 million in 2024.
- The market is expected to grow at a CAGR of 13% from 2025 to 2030.
- In terms of segment, product was the largest revenue generating product & service in 2024.
- Service is the most lucrative product & service segment registering the fastest growth during the forecast period.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2025 to 2030.
MEA data book summary
| Market revenue in 2024 | USD 107.8 million |
| Market revenue in 2030 | USD 220.9 million |
| Growth rate | 13% (CAGR from 2025 to 2030) |
| Largest segment | Product |
| Fastest growing segment | Service |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Product, Service |
| Key market players worldwide | AstraZeneca PLC, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, CRISPR Therapeutics AG, Editas Medicine Inc, Roche Holding AG, PerkinElmer, Genscript Biotech Corp Class H, Danaher Corp, Intellia Therapeutics Inc, Lonza Group Ltd, Merck KGaA, Takara Bio Inc, Thermo Fisher Scientific Inc, Cibus Inc Ordinary Shares - Class A, Beam Therapeutics Inc, Vertex Pharmaceuticals Inc, Addgene, EGenesis, Synthego, Mammoth Biosciences, Inscripta, PLANTEDIT, Hera Biotech, Origene Technologies, Recombinetics |
Other key industry trends
- In terms of revenue, MEA region accounted for 2.3% of the global crispr and cas genes market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 3,185.9 million by 2030.
Product was the largest segment with a revenue share of 85.25% in 2024. Horizon Databook has segmented the Middle East & Africa crispr and cas genes market based on product, service covering the revenue growth of each sub-segment from 2018 to 2030.
This region was observed to have the lowest market penetration in 2019. However, in the coming years, the MEA market is expected to witness considerable growth, owing to the growing importance of CRISPR technologies in human disease treatment.
Moreover, clinical studies conducted on the use of gene-editing in agriculture is expected to impact the growth of MEA’s GM crop industry. Researchers are continuously employing this technology for the development of novel therapies.
In May 2018, researchers from the United Arab Emirates University successfully used CRISPRCas9 technology to gain insights on disease mechanisms, finally helping them design novel therapies. The UAE ranks sixth in the globe in terms of prevalence of birth defects, which is expected to propel the demand for novel therapies.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
CRISPR And Cas Genes Market Scope
CRISPR And Cas Genes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
MEA crispr and cas genes market size, by country, 2018-2030 (US$M)
Middle East & Africa CRISPR And Cas Genes Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
